APA (7th ed.) Citation

Huang, S., Bair, P., Chang, S., Kao, Y., Chen, S., Wang, I., . . . Yu, T. (2024). Risk of Diabetic Retinopathy in Patients With Type 2 Diabetes After SGLT-2 Inhibitors: A Nationwide Population Cohort Study. Clinical pharmacology and therapeutics, 115(1), 95. https://doi.org/10.1002/cpt.3074

Chicago Style (17th ed.) Citation

Huang, Shih-Ting, et al. "Risk of Diabetic Retinopathy in Patients With Type 2 Diabetes After SGLT-2 Inhibitors: A Nationwide Population Cohort Study." Clinical Pharmacology and Therapeutics 115, no. 1 (2024): 95. https://doi.org/10.1002/cpt.3074.

MLA (9th ed.) Citation

Huang, Shih-Ting, et al. "Risk of Diabetic Retinopathy in Patients With Type 2 Diabetes After SGLT-2 Inhibitors: A Nationwide Population Cohort Study." Clinical Pharmacology and Therapeutics, vol. 115, no. 1, 2024, p. 95, https://doi.org/10.1002/cpt.3074.